Uncommon Tumors of the Oral Cavity and Adjacent Structures

Textbook of Uncommon Cancer, Third Edition

Volumn , Issue , 2006, Pages 87-101

  Kagan, A Robert ^a   Shibata, Stephen I ^b   McNicoll, Michael P ^a   Alshak, Najeeb S ^a  

^a KAISER PERMANENTE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Jaw; Lymphoma; Melanoma; Mouth cancer treatment; Salivary glands; Sarcoma

Indexed keywords

EID: 84889279724     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470030542.ch6     Document Type: Chapter

References (60)

1. Robbins KT, Yao SF. Uncommon epithelial tumors of the oral cavity. In Raghavan D, et al. (eds) Textbook of Uncommon Cancer, 2nd ed. Chichester, England: Wiley-Liss, 1998: 117-130.
2. Taylor AM, et al. Malignant odontogenic tumors. A retrospective and collaborative study of seven cases. Med Oral 2003; 8: 110-21.
3. de Lange J, van den Akker HP, Klip H. Incidence and disease-free survival after surgical therapy of central giant cell granulomas of the jaw in The Netherlands: 1990-1995. Head Neck 2004; 26(9): 792-5.
4. Messahel B, et al. Clinical features of molecular pathology of solid tumours in childhood. Lancet Oncol 2005; 6(6): 421-30.
5. Grier HE, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348(8): 694-701.
6. Kilpatrick SE, et al. Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer 1995; 76(12): 2471-84.
7. Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol 1995; 31 B: 86-99.
8. Quesada JL, et al. Ewings' sarcoma of the mandible. J Laryngol Otol 2003; 117(9): 736-8.
9. Wexler LH, et al. Combined modality treatment of Ewing's sarcoma of the maxilla. Head Neck 2003; 25(2): 168-72.
10. Grier HE, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348(8): 694-701.
11. Smith RB, et al. National Cancer Data Base report on osteosarcoma of the head and neck. Cancer 2003; 98(8): 1670-80.
12. Tabone MD, et al. Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases. J Clin Oncol 1999; 17(9): 2789-95.
13. Ruark DS, Schlehaider UK, Shah JP. Chondrosarcomas of the head and neck. World J Surg 1992; 16(5): 1010-5.
14. Prasad ML, Patel SG, Busam KJ. Primary mucosal desmoplastic melanoma of the head and neck. Head Neck 2004; 26(4): 373-7.
15. Terhaard CH, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 2004; 26(8): 681-92.
16. Bradley PJ. Distant metastases from salivary glands cancer. ORL J Otorhinolaryngol Relat Spec 2001; 63(4): 233-42.
17. Auclair PL, Goode RK, Ellis GL. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Cancer 1992; 69(8): 2021-30.
18. Lopes MA, et al. A clinicopathologic study of 196 intraoral minor salivary gland tumours. J Oral Pathol Med 1999; 28(6): 264-7.
19. Kuhel W, et al. Adenoid cystic carcinoma of the palate. Arch Otolaryngol Head Neck Surg 1992; 118(3): 243-7.
20. Batsakis JG, el Naggar AK. Terminal duct adenocarcinomas of salivary tissues. Ann Otol Rhinol Laryngol 1991; 100(3): 251-3.
21. Evans HL, Batsakis JG. Polymorphous low-grade adenocarcinoma of minor salivary glands. A study of 14 cases of a distinctive neoplasm. Cancer 1984; 53(4): 935-42.
22. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986; 8(3): 177-84.
23. Spiro RH, Huvos AG. Stage means more than grade in adenoid cystic carcinoma. Am J Surg 1992; 164(6): 623-8.
24. Bell RB, et al. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg 2005; 63(7): 917-28.
25. Agulnik M, Siu LL. An update on the systemic therapy of malignant salivary gland cancers: role of chemotherapy and molecular targeted agents. Curr Med Chem Anti-Cancer Agents 2004; 4(6): 543-51.
26. Beckhardt RN, et al. Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome. Laryngoscope 1995; 105(11): 1155-60.
27. Sunaba K, et al. Radiotherapy for primary localized (stage I and II) non-Hodgkin's lymphoma of the oral cavity. Int J Radiat Oncol Biol Phys 2000; 47(1): 179-83.
28. Takahashi H, et al. Primary extranodal non-Hodgkin's malignant lymphoma of the oral region: analysis of 11 autopsy cases. J Oral Pathol 1987; 16(5): 241-50.
29. Gurkaynak M, et al. Waldeyer's ring lymphomas: treatment results and prognostic factors. Am J Clin Oncol 2003; 26(5): 437-40.
30. Mohammadianpanah M, et al. Treatment results of tonsillar lymphoma: a 10-year experience. Ann Hematol 2005; 84(4): 223-6.
31. Cattelan AM, et al. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. J Natl Cancer Inst Monogr 2001; 28: 44-9.
32. Epstein JB, et al. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine. Cancer 1989; 64(12): 2424-30.
33. McCormick SU. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up. J Oral Maxillofac Surg 1996; 54(5): 583-7.
34. Morris AK, Valley AW. Overview of the management of AIDS-related Kaposi's sarcoma. Ann Pharmacother 1996; 30(10): 1150-63.
35. Soutar R, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Clin Oncol (R Coll Radiol) 2004; 16(6): 405-13.
36. Alexiou C, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer 1999; 85(11): 2305-14.
37. Fanburg-Smith JC, Furlong MA, Childers EL. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases. Mod Pathol 2003; 16(3): 263-71.
38. Schenberg ME, Slootweg PJ, Koole R. Leiomyosarcomas of the oral cavity. Report of four cases and review of the literature. J Craniomaxillofac Surg 1993; 21(8): 342-7.
39. Golledge J, Fisher C, Rhys-Evans PH. Head and neck liposarcoma. Cancer 1995; 76(6): 1051-8.
40. Fanburg-Smith JC, Furlong MA, Childers EL. Liposarcoma of the oral and salivary gland region: a clinicopathologic study of 18 cases with emphasis on specific sites, morphologic subtypes, and clinical outcome. Mod Pathol 2002; 15(10): 1020-31.
41. Weiss SW, et al. Epithelioid hemangioendothelioma and related lesions. Semin Diagn Pathol 1986; 3(4): 259-87.
42. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982; 50(5): 970-81.
43. Nayler SJ, et al. Composite hemangioendothelioma: a complex, lowgrade vascular lesion mimicking angiosarcoma. Am J Surg Pathol 2000; 24(3): 352-61.
44. Hamakawa H, et al. Intraosseous epithelioid hemangioendothelioma of the mandible: a case report with an immunohistochemical study. J Oral Pathol Med 1999; 28(5): 233-7.
45. Flaitz CM, et al. Primary intraoral epithelioid hemangioendothelioma presenting in childhood: review of the literature and case report. Ultrastruct Pathol 1995; 19(4): 275-9.
46. Barnes L, Kanbour A. Malignant fibrous histiocytoma of the head and neck. A report of 12 cases. Arch Otolaryngol Head Neck Surg 1988; 114(10): 1149-56.
47. Yamaguchi S, et al. Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years. Clin Oral Investig 2004; 8(2): 52-5.
48. Wanebo HJ et al., Society of Head and Neck Surgeons Committee on Research. Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Head Neck 1992; 14(1): 1-7.
49. Bras J, Batsakis JG, Luna MA. Malignant fibrous histiocytoma of the oral soft tissues. Oral Surg Oral Med Oral Pathol 1987; 64(1): 57-67.
50. Wiesmiller K, Barth TF, Gronau S. Early radiation-induced malignant fibrous histiocytoma of the oral cavity. J Laryngol Otol 2003; 117(3): 224-6.
51. Barnes L. Surgical Pathology of the Head and Neck, 2nd ed. New York: Marcel Decker, 2001.
52. Freedman AM, Reiman HM, Woods JE. Soft-tissue sarcomas of the head and neck. Am J Surg 1989; 158(4): 367-72.
53. Chen SA, et al. Adult head and neck soft tissue sarcomas. Am J Clin Oncol 2005; 28(3): 259-63.
54. Tran LM, et al. Sarcomas of the head and neck. Prognostic factors and treatment strategies. Cancer 1992; 70(1): 169-77.
55. Scurr M, Judson I. Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomas. Hematol Oncol Clin North Am 2005; 19(3): 489-500. vi.
56. Potter BO, Sturgis EM. Sarcomas of the head and neck. Surg Oncol Clin N Am 2003; 12(2): 379-417.
57. Sturgis EM, Potter BO. Sarcomas of the head and neck region. Curr Opin Oncol 2003; 15(3): 239-52.
58. Andrassy RJ. Advances in the surgical management of sarcomas in children. Am J Surg 2002; 184(6): 484-91.
59. Wharam MD, et al. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 2004; 22(10): 1902-8.
60. Breneman JC, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma-a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2003; 21(1): 78-84.